Nebulized Amikacin Versus Intravenous Amikacin in the Treatment of Nosocomial Pneumonia
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
The investigator's goal in this study is to evaluate the efficacy and safety of nebulized
amikacin versus intravenous amikacin in patients with hospital and ventilator acquired
pneumonia in surgical patients admitted to the intensive care units infected with gram
negative bacilli